It wasn't just MSB saying that.
" Novartis Pharmaceuticals spokesman told the Financial Review the work between the pair was ongoing.
“The agreement remains subject to certain closing conditions – including an appropriate amount of time to analyse the full results from the phase 3 COVID-19 ARDS trial,” he said. “The work between Novartis and Mesoblast is ongoing, and that is all that we can say at this time.” "
https://www.copyright link/companies/healthcare-and-fitness/mesoblast-says-fda-has-not-put-a-hold-on-drug-trial-20210901-p58nqp
That link is for the AFR
Ann: Litigation Update, page-78
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
0.035(2.89%) |
Mkt cap ! $1.421B | |||
| Open | High | Low | Value | Volume |
| $1.21 | $1.25 | $1.18 | $4.096M | 3.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22000 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 36989 | 4 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |